Bull Harbor Capital LLC bought a new stake in Agilent Technologies, Inc. (NYSE:A – Free Report) in the 1st quarter, according to its most recent disclosure with the SEC. The fund bought 5,592 shares of the medical research company’s stock, valued at approximately $637,000.
Several other hedge funds have also modified their holdings of A. Core Wealth Advisors LLC purchased a new stake in shares of Agilent Technologies during the 4th quarter worth $26,000. SHP Wealth Management acquired a new position in Agilent Technologies in the fourth quarter valued at approximately $26,000. Navalign LLC purchased a new stake in shares of Agilent Technologies during the fourth quarter worth about $27,000. Cedar Mountain Advisors LLC purchased a new stake in shares of Agilent Technologies during the 1st quarter valued at about $27,000. Finally, MV Capital Management Inc. purchased a new position in shares of Agilent Technologies in the fourth quarter valued at $28,000.
Analyst Ratings Changes
Several research firms have issued reports on A. HSBC dropped their price objective on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a report on Wednesday, June 3rd. Robert W. Baird lifted their price target on shares of Agilent Technologies from $155.00 to $156.00 and gave the stock an “outperform” rating in a research report on Tuesday, May 26th. Bank of America upgraded Agilent Technologies from a “neutral” rating to a “buy” rating and decreased their price target for the company from $150.00 to $145.00 in a research report on Thursday, May 28th. Jefferies Financial Group began coverage on Agilent Technologies in a report on Thursday, July 9th. They set a “hold” rating and a $135.00 price target on the stock. Finally, Weiss Ratings upgraded shares of Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, June 2nd. Two equities research analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $159.35.
Agilent Technologies Stock Down 1.1%
A opened at $138.72 on Friday. The company has a market capitalization of $39.18 billion, a P/E ratio of 27.86, a P/E/G ratio of 2.49 and a beta of 1.25. The firm’s fifty day moving average price is $131.89 and its two-hundred day moving average price is $125.21. Agilent Technologies, Inc. has a fifty-two week low of $108.35 and a fifty-two week high of $160.27. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62.
Agilent Technologies (NYSE:A – Get Free Report) last posted its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.41 by $0.08. The firm had revenue of $1.83 billion during the quarter, compared to analyst estimates of $1.80 billion. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The company’s quarterly revenue was up 10.0% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. On average, analysts anticipate that Agilent Technologies, Inc. will post 6.01 EPS for the current year.
Agilent Technologies Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th were given a dividend of $0.255 per share. The ex-dividend date was Tuesday, June 30th. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.7%. Agilent Technologies’s payout ratio is presently 20.48%.
Agilent Technologies Profile
Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.
Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.
Read More
- Five stocks we like better than Agilent Technologies
- Microsoft Just Flipped the AI Spending Narrative Overnight
- Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling?
- Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending
- Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A – Free Report).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
